Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial

Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-25T15:33:17.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T16:19:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:58:10.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the standard 403 layout, replacing the study content. This indicates restricted access to the NCT03504488 record.
    Difference
    18%
    Check dated 2026-09-20T20:58:27.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.6.6' was added, and the previous 'Revision: v3.6.5' tag was removed. The change updates the page's revision metadata rather than its substantive content.
    Difference
    0.0%
    Check dated 2026-08-30T15:49:40.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-08-08T23:24:01.000Z thumbnail image

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.